Our top pick for
Building a portfolio
Acadia Healthcare Company, Inc is a medical care facilities business based in the US. Acadia Healthcare Company shares (ACHC) are listed on the NASDAQ and all prices are listed in US Dollars. Acadia Healthcare Company employs 28,600 staff and has a trailing 12-month revenue of around 0.00.
|52-week range||$21.27 - $63.06|
|50-day moving average||$59.18|
|200-day moving average||$49.53|
|Wall St. target price||$62.82|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$1.13|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Acadia Healthcare Company stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Acadia Healthcare Company's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Acadia Healthcare Company's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.32. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Acadia Healthcare Company's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Acadia Healthcare Company's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $448.8 million.
The EBITDA is a measure of a Acadia Healthcare Company's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$2.1 billion|
|Operating margin TTM||16.49%|
|Gross profit TTM||$848.2 million|
|Return on assets TTM||3.91%|
|Return on equity TTM||6.07%|
|Market capitalisation||$5.4 billion|
TTM: trailing 12 months
There are currently 4.2 million Acadia Healthcare Company shares held short by investors – that's known as Acadia Healthcare Company's "short interest". This figure is 1.6% down from 4.3 million last month.
There are a few different ways that this level of interest in shorting Acadia Healthcare Company shares can be evaluated.
Acadia Healthcare Company's "short interest ratio" (SIR) is the quantity of Acadia Healthcare Company shares currently shorted divided by the average quantity of Acadia Healthcare Company shares traded daily (recently around 530083.92405063). Acadia Healthcare Company's SIR currently stands at 7.9. In other words for every 100,000 Acadia Healthcare Company shares traded daily on the market, roughly 7900 shares are currently held short.
However Acadia Healthcare Company's short interest can also be evaluated against the total number of Acadia Healthcare Company shares, or, against the total number of tradable Acadia Healthcare Company shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Acadia Healthcare Company's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Acadia Healthcare Company shares in existence, roughly 50 shares are currently held short) or 0.0614% of the tradable shares (for every 100,000 tradable Acadia Healthcare Company shares, roughly 61 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Acadia Healthcare Company.
Find out more about how you can short Acadia Healthcare Company stock.
We're not expecting Acadia Healthcare Company to pay a dividend over the next 12 months.
Acadia Healthcare Company's shares were split on a 1:4 basis on 31 October 2011. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Acadia Healthcare Company shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Acadia Healthcare Company shares which in turn could have impacted Acadia Healthcare Company's share price.
Over the last 12 months, Acadia Healthcare Company's shares have ranged in value from as little as $21.27 up to $63.06. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Acadia Healthcare Company's is 1.5626. This would suggest that Acadia Healthcare Company's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States and Puerto Rico. The company operates acute inpatient psychiatric facilities, which cares to stabilize patients that are either threat to themselves or others by hourly observation, daily intervention, and monitoring by psychiatrists; and specialty treatment facilities, including residential recovery and eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders. It also provides residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs; and outpatient community-based services, such as community-based programs that are designed to offer therapeutic treatment to children and adolescents who have a clinically-defined emotional, psychiatric, or chemical dependency disorders. In addition, the company provides education and children's, and adult care services. As of December 31, 2020, it operated a network of 572 behavioral healthcare facilities with approximately 18,100 beds. The company was founded in 2005 and is headquartered in Franklin, Tennessee.
Everything we know about the Krispy Kreme IPO, plus information on how to buy in.
Everything we know about the Day One Biopharmaceuticals IPO, plus information on how to buy in.
Everything we know about the Enact Holdings IPO, plus information on how to buy in.
Everything we know about the Solid Power IPO, plus information on how to buy in.
Everything we know about the Paymentus Holdings IPO, plus information on how to buy in.
Everything we know about the Qiniu Limited IPO, plus information on how to buy in.
Everything we know about the Qiniu Limited IPO, plus information on how to buy in.
Everything we know about the Ximalaya IPO, plus information on how to buy in.
Everything we know about the Zeta Global Holdings Corp IPO, plus information on how to buy in.
Everything we know about the Paycor HCM IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.